CSF1 and neoplasm: In addition to neutrophils, LY500307 inhibited the expression of CSF-1 in tumor cells, leading to reduced recruitment of myeloid-derived suppressor cells (MDSC) and an increase in CD8+ cytotoxic T cells in the tumor microenvironment [113].